Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
11 févr. 2022 07h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
07 févr. 2022 07h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Appoints Prathyusha Duraibabu to Board of Directors
22 nov. 2021 07h00 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Third Quarter and First Nine Months 2021 Financial Results
09 nov. 2021 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Participate in the Credit Suisse 30th Annual Healthcare Conference
08 nov. 2021 07h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Fall 2021 Conference
27 oct. 2021 09h25 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021
07 oct. 2021 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
10 sept. 2021 09h00 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
09 août 2021 16h03 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Announces New $200 Million Credit Agreement with Silicon Valley Bank
09 août 2021 16h01 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...